Craig Pheiffer from Absa Stockbrokers & Portfolio Management chose AbbVie as his stock pick of the day.

“I’m again looking offshore at AbbVie, it’s a $100bn offshore pharmaceutical company ... It’s come off quite sharply and Humira is a big selling point and that’s probably the world’s biggest-selling drug of 2018.”..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.